Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid

AIDS Research and Human Retroviruses

Volumn 17, Issue 5, 2001, Pages 377-383

  Cinque, P ^a   Presi, S ^a   Bestetti, A ^a   Pierotti, C ^a   Racca, S ^a   Boeri, E ^a   Morelli, P ^a   Carrera, P ^a   Ferrari, M ^a   Lazzarin, A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NUCLEOTIDE; PROTEINASE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; STAVUDINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC RESISTANCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS RESISTANCE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CEREBROSPINAL FLUID; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PREDICTIVE VALUE OF TESTS; SEQUENCE ALIGNMENT; VIRAL LOAD; VIREMIA;

EID: 0035794303     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201750102409     Document Type: Article

References (34)

1. The brain in AIDS: Central nervous system HIV infection and AIDS dementia complex
2. Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy
3. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy
4. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
5. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
6. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
7. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
8. Molecular analysis of cerebrospinal fluid: Potential for the study of HIV-1 infection of the central nervous system
9. Cerebrospinal fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
10. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebropsinal fluid during combination treatment with zidovudine, lamivudine and indinavir
11. Time course of cerebrospinal fluid responses to antiretroviral therapy: Evidence for variable compartmentalization of infection
12. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid
13. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
14. Antiretroviral drug resistance testing in adult HIV-1 infection
15. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment
16. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues
17. Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1-infected patients
18. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
19. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid
20. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid of patients with lymphocytic meningitis
21. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels
22. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection
23. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients
24. Numbering positions in HIV relative to HXB2CG
25. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers
26. Resistance table: Mutations in retroviral genes associated with drug resistance
27. Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
28. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors
29. Antiretroviral drugs and the central nervous system
30. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine
31. Diminished HIV-1 sensitivity to stavudine in patients on prolonged therapy occurs only at low levels and cannot be attributed to any single amino acid substitution in reverse transcriptase
32. Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy
33. Impact of drug resistance mutations on virologic response to salvage therapy
34. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: Genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS Clinical Trials Group Protocol 315